Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-05

Clinical Trial Update: Tranexamic Acid in Proximal Humeral Fractures [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating tranexamic acid for proximal humeral fractures undergoing surgical treatment. Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Elda University Hospital | Conditions: Proximal Humeral Fracture, Surgical Treatment | Phase 4 | Status: UNKNOWN